Bedaquiline-based regimen for pre-XDR TB: duration and monitoring protocol?

34F with pre-XDR TB (resistant to isoniazid, rifampicin, and fluoroquinolones). Sputum culture confirmed M. tuberculosis with susceptibility to bedaquiline, linezolid, and clofazimine. No prior TB treatment (primary resistance).

She also has HIV (CD4 count 180, on TDF/3TC/DTG).

Questions for the group:

What is your preferred shorter regimen composition? BPaL (bedaquiline, pretomanid, linezolid) vs the WHO longer regimen?
Linezolid dose and duration? The myelosuppression and neuropathy risk concerns me.
QTc monitoring protocol with bedaquiline + DTG?
Timing of ART adjustment relative to TB treatment initiation?
Any experience with pretomanid availability in India?

This is a scenario we encounter with increasing frequency. Here is my approach:

1. Regimen choice: I favor the BPaL regimen (bedaquiline + pretomanid + linezolid) based on the TB-PRACTECAL and ZeNix trial results. The shorter duration (26 weeks) and higher cure rates (>89%) compared to the older 18 to 20 month injectable-based regimens make it the preferred choice. However, pretomanid availability in India is still limited. If pretomanid is unavailable, I use bedaquiline + linezolid + clofazimine + cycloserine as a 4-drug combination for 18 to 20 months.

2. Linezolid dosing: The ZeNix trial demonstrated that linezolid 600mg daily for the full 26 weeks was optimal. Some centers use 1200mg initially and step down, but the 600mg arm had equivalent efficacy with fewer adverse events. Weekly CBC for the first 2 months, then biweekly. I watch for peripheral neuropathy symptoms at every visit and do baseline and monthly visual acuity testing to catch optic neuropathy early.

3. QTc monitoring: Bedaquiline causes QTc prolongation (mean increase 15 to 20ms). DTG has minimal QTc effect. I get baseline ECG, then repeat at 2 weeks, 4 weeks, and monthly thereafter. If QTc > 500ms, I consider separating bedaquiline and DTG dosing by 12 hours. If QTc > 550ms, I involve cardiology and consider bedaquiline dose modification.

4. ART timing: Since she is already on ART, continue without interruption. DTG does not have clinically significant interactions with bedaquiline. However, if she were ART-naive, I would start TB treatment first and add ART at 2 to 8 weeks depending on CD4 count and risk of IRIS.

One additional consideration I want to flag: drug-drug interactions. Bedaquiline is metabolized by CYP3A4. While DTG does not significantly affect CYP3A4, if this patient requires any azole antifungals (common with CD4 180), fluconazole and itraconazole will increase bedaquiline levels. Rifabutin, which is sometimes considered in HIV co-infection, is contraindicated with bedaquiline because it reduces bedaquiline concentrations by 50%.

Also, linezolid is a weak MAO inhibitor. Dietary tyramine restriction is not typically necessary at 600mg daily, but I counsel patients to avoid large quantities of aged cheese, fermented foods, and tap beer. This sounds trivial but in practice I have seen a hypertensive crisis from this interaction once.

2 Answers